Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' reply.

Autor: Aliu A; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Bosch DHCA; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Keszthelyi D; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Ardabili AR; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Colombel JF; Department of Medicine, The Henry D. Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Sawyer R; IBD Patient Advocacy, Founder of the Bottom Line IBD and IBD Women, London, UK., Törnblom H; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Hart A; IBD Unit, St Mark's Hospital & Imperial College, London, UK., Jonkers DMAE; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Pierik MJ; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Mujagic Z; Department Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, The Netherlands.; NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Jun; Vol. 59 (12), pp. 1646-1647. Date of Electronic Publication: 2024 May 10.

Letter: Light in the lumen-The expanding role of intestinal ultrasound for functional symptoms in inflammatory bowel disease.

Autor: Mathias RM; Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.; Inflammatory Bowel Disease Research Group, The Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia.; School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia., Bryant RV; Inflammatory Bowel Disease Service, The Queen Elizabeth Hospital, Adelaide, South Australia, Australia.; Inflammatory Bowel Disease Research Group, The Basil Hetzel Institute for Translational Health Research, Adelaide, South Australia, Australia.; School of Medicine, Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Sep; Vol. 60 (6), pp. 833-834. Date of Electronic Publication: 2024 Aug 06.